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Abstract
Normothermic regional perfusion (NRP) is used to restore the flow of oxygen-
ated blood following cardiac arrest and reverse warm ischemic injury in donation 
after circulatory death (DCD) organ transplantation. The use of NRP in this setting 
has typically been limited to the abdominal cavity, though its use has recently been 
expanded to chest to help recover DCD hearts, as well. This chapter evaluates the 
principles behind the use of NRP in DCD organ transplantation as well as not only 
technical but also ethical and legal aspects associated with its application and the 
clinical results that have been achieved to date when it has been used to recover 
various solid organs through the DCD process.
Keywords: controlled donation after circulatory death, kidney transplantation,  
liver transplantation, uncontrolled donation after circulatory death, warm ischemia
1. Introduction
Donation after circulatory death (DCD) donors, which are declared dead 
following cardiorespiratory arrest, are an increasingly more common source of 
organs for transplantation. They may be classified among four categories depend-
ing on events and conditions surrounding arrest: category I, dead on arrival (no 
attempt at resuscitation); category II, sudden cardiac arrest followed by unsuc-
cessful resuscitation; category III, arrest following intentional withdrawal of 
life support in ventilated patient not meeting brain death criteria; and category 
IV, cardiac arrest while brain dead. Categories 1, 2 and 4 are classified as uncon-
trolled DCD (uDCD) and category 3 as controlled DCD (cDCD) [1]. In practice, 
category III cDCD and, to a lesser extent, category II uDCD donors comprise 
essentially all DCD donors that are used for transplantation globally. The period 
of warm ischemia surrounding arrest, however, provokes organ injury, and DCD 
in general yields fewer organs per donor and ones of inferior quality when com-
pared with donation after brain death (DBD) [2]. For this reason, there has been 
increasing interest in forgoing rapid cold preservation and recovery following the 
declaration of death (still the “gold standard” for DCD organ recovery in most 
transplant centers) and instead using normothermic regional perfusion (NRP) 
to temporarily restore oxygenated blood flow the abdominal and more recently 
thoracic organs prior to recovery.
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2.  Principles behind the use of normothermic regional perfusion in 
donation after circulatory death
During warm ischemia, ATP degradation leads to the progressive accumulation 
of xanthine and hypoxanthine, important sources of superoxide radical at organ 
reperfusion [3]. A period of post-ischemic NRP in DCD donors is useful to restore 
cellular energy substrates [4], reduce levels of nucleotide degradation products [5], 
improve the concentrations of endogenous antioxidants [6], and even stimulate 
processes of cellular repair prior to graft recovery [7] (Figure 1). An experimental 
study demonstrates that by blocking the A2 receptors of adenosine, the beneficial 
effects of NRP are abolished, indicating that NRP mediates its effect, at least in 
part, through adenosine as a form of ischemic preconditioning [8]. Post-ischemic 
NRP may also be useful to reduce the vasoconstrictive effects of cold graft washout 
with the static cold storage solution [9] and offers an opportunity to assess organ 
viability prior to recovery [10, 11].
3.  Techniques for establishing normothermic regional perfusion in 
donation after circulatory death
While NRP relies on extracorporeal membrane oxygenation (ECMO) technol-
ogy, its clinical application is, in general, less complex than that of therapeutic 
ECMO. A venous cannula is placed to derive blood from the donor inferior vena 
cava or right atrium, which is then pumped through a membrane oxygenator and a 
heat exchanger before returning to the donor arterial bed (aorta or iliac or femoral 
artery). An in-line reservoir may be included in the circuit, as well, to allow for 
replacement of volume prior to circuit failure in the event of volume loss or inad-
equate venous return due to severe vasoplegia (particularly relevant in the setting 
Figure 1. 
During ischemia, the concentrations of adenine nucleotides (ATP, ADP, AMP) and nucleosides (adenosine, 
inosine) progressively decline. Also, the concentrations of nucleotide breakdown products (xanthine, 
hypoxanthine) increase, thereby leading to the production of oxygen free radicals upon reperfusion. 
Normothermic regional perfusion is capable of reversing these processes and increases the concentrations of 
endogenous antioxidants, effectively recharging and reconditioning organs in the abdomen and chest prior to 
recovery for transplantation.
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of uDCD). The precise positioning of occlusion balloon catheters or clamps used to 
exclude other vascular beds is what determines whether NRP is either thoracoab-
dominal or abdominal only.
3.1 Abdominal normothermic regional perfusion
In uDCD, cannulation for the establishment of abdominal NRP is performed 
post-mortem after death is declared, typically in the emergency department. In 
cDCD, in contrast, cannulation for abdominal NRP may be performed either prior 
to the withdrawal of life support (pre-mortem) or following the declaration of 
death. Pre-mortem cannulation may be performed either percutaneously or via fem-
oral cut-down in a variety of settings (intensive care unit, radiology suite, operating 
room). Post-mortem cannulation, on the other hand, is most often done in open 
abdomen in the operating room, though some centers have used femoral artery and 
vein catheters or guidewires placed prior to withdrawal of care to access and thereby 
cannulate the femoral vasculature following the declaration of death [12].
For uDCD donors and cDCD donors with pre-mortem cannulation, a bolus of 
heparin is administered, and cannulation of unilateral femoral vessels is performed 
either via open femoral cutdown and isolation of the femoral artery and vein or 
percutaneously using Seldinger technique [11]. Cannulae are left clamped and 
connected to the tubing of the primed NRP circuit. The contralateral femoral artery 
is also cannulated with an aortic occlusion balloon catheter, which is left deflated 
in the case of cDCD and advanced into the supraceliac aorta under radiographic 
control. Following the withdrawal of life support and the declaration of death in 
cDCD, the aortic occlusion balloon is inflated, and the abdominal NRP circuit is 
initiated (Figure 2). Proper positioning of the balloon excluding the aortic arch ves-
sels is confirmed by chest radiograph and absence of flow measured in a left radial 
arterial catheter.
For cDCD donors undergoing open post-mortem cannulation, once death has been 
declared, the surgical team performs midline laparotomy to cannulate the abdominal 
aorta immediately proximal to and the infrarenal inferior vena cava immediately 
distal to their respective bifurcations. Cannulae are connected to the tubing of the 
primed NRP circuit, the supraceliac aorta is clamped, and NRP is initiated.
Blood is sampled at baseline and every 30 minutes during abdominal NRP to deter-
mine biochemical, hematological, and acid-base parameters. In general, pump flow is 
maintained >1.7 L/min/m2, temperature 35–37°C, PaO2 100–150 mmHg, and hemo-
globin >7 g/dL. Hepatic transaminases should remain stable throughout NRP; levels 
>3× the upper limit of normal at baseline and/or >4× the upper limit of normal at the 
end of NRP may be considered relative contraindications for recovery of the liver and 
pancreas [10, 11]. In general, NRP is run for a minimum of 1 hour and a maximum 
of 4 hours to allow adequate reconditioning of the abdominal organs and recovery of 
energy substrates without provoking additional end-organ injury [4, 5, 7, 8, 13, 14].
3.2 Thoracoabdominal normothermic regional perfusion
While the circuit for abdominal NRP may be established pre-mortem, cannula-
tion to establish a complete thoracoabdominal NRP circuit is done post-mortem in 
the operating room. After the declaration of death, the chest is entered through a 
midline sternotomy, and the pericardium is opened. A bolus of heparin is injected 
into the heart directly, an arterial cannula is inserted into the distal ascending 
aorta/aortic arch, and a venous cannula is inserted into the right atrium. Cannulae 
are connected to the tubing of the primed NRP circuit, the aortic arch vessels are 
clamped, and NRP is initiated.
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During thoracoabdominal NRP, pump flow is maintained ≥2.5 L/min/m2, tem-
perature 35°C, and hemoglobin >10 g/dL. Prompt laparotomy is performed to assess 
hepatic and intestinal perfusion and to exclude the lower extremities from the 
perfusion circuit. Once cardiac contractility has been restored, weaning from NRP 
is attempted. If the heart is able to take over circulation, functional assessment is 
performed using transesophageal echocardiography and pulmonary artery flotation 
catheter (Swan-Ganz) monitoring. In general, acceptance criteria for a cDCD heart 
recovered with NRP include central venous pressure ≤12 mmHg, pulmonary capil-
lary wedge pressure ≤12 mmHg, cardiac index ≥2.5 L/min/m2, and left ventricular 
ejection fraction ≥50% [15–17].
4.  Clinical outcomes using normothermic regional perfusion in donation 
after circulatory death
To date, the great majority of human transplants performed using organs 
recovered with NRP have been donor using DCD kidneys and livers. In more recent 
years, the use of DCD pancreata and even hearts recovered with NRP has also been 
reported.
Figure 2. 
Abdominal normothermic regional perfusion. Cannulae are placed in the femoral artery and vein in the groin 
region. A Fogarty balloon catheter is introduced through the contralateral femoral artery and positioned in the 
supraceliac abdominal or thoracic aorta.
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4.1 Kidney transplantation
When compared with other solid organs for transplantation, the kidney is 
relatively resilient and withstands the ischemic insult inherent to the DCD pro-
cess relatively well. Nonetheless, kidneys from DCD donors recovered with NRP 
as opposed to rapid in situ cold preservation or hypothermic perfusion/“total 
body cooling” (TBC) have demonstrated significantly better immediate as well 
as ongoing graft function [18–20]. Reports from different groups in Europe, the 
United States, and Asia have described the use of NRP in both uDCD and cDCD 
kidney transplantation, with rates of delayed graft function (DGF) around 50–70% 
and 30–40%, respectively; negligible (if any) primary non-function (PNF); and 
excellent 1-, 5-, and even 10-year graft survival rates [19–27]. While reported rates 
of DGF may still seem to be high even among DCD kidneys recovered with NRP 
(especially those arising through uDCD), the pathogenesis and, consequentially, 
implications of DGF seem to be less severe than those associated with DGF aris-
ing in the context of DBD kidney transplantation. Ischemic injury appears to be 
implicated to a greater extent in the development of DGF among DCD kidneys, 
whereas, in DBD, alloimmune phenomena prevail [28]. A recent large single-center 
study reported 73% DGF among 237 uDCD kidneys recovered with NRP versus 
46% among a contemporary cohort of matched DBD kidneys, but 10-year graft 
survival rates did not vary at all between the two groups and were excellent in both 
(82 and 80%, respectively). The authors also noted that while donor age >50 years 
was significantly associated with graft loss among uDCD kidneys, the development 
of DGF in the immediate post-transplant period was not [27].
4.2 Liver transplantation
The cells of the liver, in particular those lining the biliary tree, are particularly 
sensitive to warm ischemia, and initial experiences with DCD liver transplantation 
described high rates of graft dysfunction and non-function and non-anastomotic bili-
ary strictures/ischemic type biliary lesions (ITBL) in up to 50% of cases [29]. While 
complication rates have improved with experience, the rate of post-transplant ITBL 
remains higher among recipients of DCD versus DBD grafts: 16 versus 3%, according 
to two meta-analyses [30, 31]. The clinical relevance of ITBL lies in the fact that up to 
70% of patients with ITBL require re-transplantation or die [32].
After an initial period where different donor maintenance techniques were used, 
including rapid in situ cold preservation, simultaneous chest and abdominal compres-
sions, and TBC, NRP has come to be the “gold standard” and primary means by which 
uDCD livers are recovered for transplantation. Using NRP, even livers with extensive 
pre-recovery warm ischemic periods of up to 2.5 hours have been successfully trans-
planted, with biliary complication and graft survival rates comparable to those seen 
using cDCD livers that have suffer considerably less warm ischemia [10, 11, 33–35].
In spite of its relative success in the setting of uDCD, the application of NRP in 
cDCD liver transplantation remains more limited. The great majority of cDCD livers 
that are transplanted in the world today are still recovered with rapid in situ cold 
preservation, and reports on the use of NRP in cDCD liver transplantation have been, 
until recently, anecdotal [12, 24–26, 36, 37]. In the past year, however, two larger 
multicenter studies have come out describing the benefits that may be achieved with 
post-mortem NRP in cDCD liver transplantation. First, a Spanish national study 
compared the results of 95 cDCD liver transplants performed with post-mortem 
NRP with those of 117 cDCD liver transplants performed with super rapid recovery 
(SRR). Median donor age in the study was relatively high (57 years [25-75% inter-
quartile range, IQR 45–65] NRP, 56 years [25-75% IQR, 47–64] SRR). With a median 
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follow-up of 20 months, the use of post-mortem NRP appeared to significantly 
reduce rates of postoperative biliary complications (overall 8% NRP vs. 31% SRR, 
p < 0.001; ischemic type biliary lesions 2% NRP vs. 13% SRR, p = 0.008) and graft 
loss (12% NRP vs. 24% SRR, p = 0.008) [38]. Similarly, a combined experience from 
centers in Cambridge and Edinburgh in the United Kingdom compared the results of 
43 cDCD liver transplants performed with post-mortem NRP with those of a con-
temporary cohort of 187 cDCD liver transplants performed with SRR. Median donor 
age was less for cDCD livers with NRP versus those with SRR: 41 years (25-75% IQR 
33–57) vs. 54 years (25-75% IQR 38–63), respectively. Reported rates of anastomotic 
biliary strictures were 7% NRP vs. 27% SRR (p = 0.004), ITBL 0 NRP vs. 27% SRR 
(p < 0.001), and 90-day graft loss 2% NRP vs. 10% SRR (p = 0.102) [39].
4.3 Pancreas transplantation
The Michigan Group described one cDCD pancreas transplant in which the 
donor was maintained with NRP, though the outcome of the graft was not men-
tioned [24]. In another multicenter report from the United Kingdom, two SPK were 
described (again, outcomes not mentioned), and two more pancreata were sent for 
isolation of islets, one with good yield [25]. In Spain, where NRP is now routinely 
used to recover abdominal organs when cDCD liver and/or pancreas transplantation 
is contemplated, a total of five cDCD pancreas transplants were performed between 
2015 and 2017, and all these grafts remain functional at the time of this writing [40].
4.4 Heart transplantation
The application of thoracoabdominal NRP has been described in clinical 
series on cDCD heart transplantation; however, no report has been published to 
date describing the transplantation of the lungs from these same cDCD donors. 
(Transplantation of DCD lungs recovered with “dual temperature” in situ cold 
flushing in the chest with abdominal NRP running simultaneously, on the other 
hand, has been described and is performed routinely in some settings.) The fact 
remains that DCD donor lungs tolerate warm ischemia and the process of DCD 
donation and recovery relatively well, and post-DCD lung transplantation outcomes 
without NRP appear to be comparable to those of DBD lung transplantation [41].
The cDCD heart, on the other hand, is more susceptible to warm ischemic 
injury, and cDCD hearts recovered and transplanted after in situ cold preserva-
tion followed by static ex situ cold storage can offer suboptimal outcomes. A 
recent report on pediatric cDCD heart transplantation describes 61% 1-year graft 
survival as opposed to 91% for DBD hearts of similar baseline characteristics [42]. 
Performing thoracic NRP, on the other hand, allows for restoration of contractile 
function and performance of a standard functional assessment in ischemically 
injured cDCD cardiac allografts prior to recovery. Clinical application of thoracoab-
dominal NRP in cDCD heart transplantation has been described by the Papworth 
Hospital Group from the United Kingdom. In combination with subsequent ex situ 
normothermic machine perfusion (NMP), the use of thoracoabdominal NRP has 
allowed 100% utilization of organs subsequently undergoing NMP and lower early 
allograft dysfunction versus cDCD hearts undergoing NMP only (8% vs. 17%, 
respectively) [16, 17]. Thoracoabdominal NRP followed by static cold storage has 
even been used to successfully transplant a cDCD heart procured at the same center 
[17]. If broader application of this last strategy is shown to be just as efficacious, 
it has the potential to significantly reduce the costs associated with cDCD heart 
transplantation by obviating the need for ex situ NMP, which is a very expensive 
modality costing approximately $45,000 for each heart perfusion unit.
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5.  Ethical and legal concerns surrounding the use of normothermic 
regional perfusion in donation after circulatory death
There are some ethical concerns surrounding the use of NRP in donation after 
circulatory death, and laws vary from one country to another regarding whether or 
not NRP may be applied in DCD and, if so, how and when.
5.1 Uncontrolled donation after circulatory death
In uDCD, cardiac arrest is sudden and unexpected, and death is declared based 
on the irreversible loss of cardio-respiratory function (demonstrated after pro-
longed efforts to reverse it have failed). Death is usually declared in the emergency 
room by a team entirely independent of that responsible for organ recovery and 
preservation. More often than not, potential uDCD donors are declared dead prior 
to the arrival of next-of-kin. Based on a consequentialist ethical standpoint and the 
principles of utility and donor autonomy, certain countries, including Spain and 
France, allow cannulation maneuvers to commence in this setting, even in cases 
where first-person consent may not have yet been obtained [43, 44]. The will of 
the patient regarding donation is always subsequently investigated in the context 
a family interview, where information regarding the circumstances of the arrest, 
the outcome of resuscitation maneuvers, and the measures taken related to the 
donation process is relayed. Next-of-kin then decide, taking into consideration the 
potential donor’s wishes, whether to proceed with donation or abort the process.
It should be clear that NRP is organ maintenance and not therapy. While the 
technology employed is similar, terms such as “extracorporeal membrane oxygen-
ation/ECMO” and “extracorporeal life support/ECLS” should not be used in relation 
to organ donation. Such terminology is confusing, especially considering the fact 
that it is used to describe therapeutic maneuvers that may be used to recover patients 
suffering sudden cardiac arrest more commonly occurring inside the hospital itself.
5.2 Controlled donation after circulatory death
In cDCD, the usual stand-down period of 2–5 min of asystole that is used to declare 
death does not necessarily reflect an irreversible loss of cardiac function, evidenced 
by the fact that cDCD hearts have been recovered and successfully transplanted [17, 
45]. The “irreversibility” of death in cDCD is therefore predicated on the concept of 
permanence—the fact that loss of cardiac function will eventually become irreversible 
because it will not be reversed (and eventually lead to the loss of all brain and brain 
stem functions, as well). As it re-establishes circulation to some parts of the body, 
however, the use of NRP in this context remains controversial. At the least, clear and 
effective measures need to be put in place to ensure that cerebral reperfusion does not 
occur when NRP is established. Through the use of NRP, circulation is only restored to a 
limited region of the body, and a critical aspect of NRP in cDCD is ensuring lack of flow 
to the aortic arch vessels, thereby maintaining the permanence of circulatory arrest 
in the brain and brainstem. With pre-mortem cannulation, positioning of the aortic 
occlusion balloon in the supradiaphragmatic aorta distal to the left subclavian artery 
is confirmed radiographically prior to withdrawal of care. As additional measure, the 
aortic occlusion balloon may be briefly inflated for a few seconds prior to ventilatory 
withdrawal, in order to ensure disappearance of femoral arterial pressure and simul-
taneous maintenance of a normal pressure waveform in the left radial arterial line. In 
doing so, the minimum filling volume needed to entirely blocks the supradiaphragmatic 
aorta may be recorded [46]. Once NRP is initiated, adequate occlusion is confirmed 
through the use of a left radial artery catheter demonstrating absence of flow.
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The timing of when cannulation for abdominal NRP may be performed in 
potential cDCD donors varies by country. In certain countries, such as Spain and the 
United States, pre-withdrawal heparinization and cannulation are permitted  
[24, 43]. In the United Kingdom, on the other hand, a potential cDCD donor may only 
be cannulated once death has been declared [25]. Pre-mortem cannulation is advanta-
geous in that it is performed in a less stressful and more orderly fashion, and regional 
perfusion may be commenced immediately after the death declaration, thereby limit-
ing the length of warm ischemia suffered. Ideally, pre-mortem cannulation should be 
performed in the least invasive manner possible (e.g., percutaneously).
6. Summary and future directions
Table 1 summarizes the current state of NRP in the various fields of clinical DCD 
organ transplantation. The application of post-mortem NRP appears particularly rele-
vant and advantageous in DCD kidney, liver, and heart transplantation, and the future 
will tell if it can have impact the fields of DCD pancreas and lung transplantation, as 
well. Some ethical concerns remain surrounding its use, primarily in the context of 
cDCD, and clear and effective steps need to always be taken to ensure lack of reperfu-
sion of the brain and brainstem once NRP has been initiated. Through these measures 
and continued dialog with both intensive care as well as extra- and intrahospitalary 
emergency medical professionals, the hope is that the use of NRP and, thereby, DCD 
organ transplantation in general may be expanded to offer more organs and ones of 
better quality to a greater number of patients with end-stage organ disease.
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Kidney Lower rates of immediate post-transplantation delayed graft function and 
primary non-function and improved ongoing graft function among both 
uDCD and cDCD allograft recipients.
Liver Lower rates of post-transplantation biliary complications, including ischemic 
type biliary lesions, and less graft loss among cDCD livers; considered 
essential for the evaluation and recovery of uDCD livers
Pancreas Feasible, though more experience is required to determine its true impact
Lung No reports to date
Heart Less early allograft dysfunction; allows for in situ functional assessment that 
can not only help avoid subsequent costly and potentially unsuccessful ex situ 
normothermic machine perfusion functional assessment but perhaps even 
the use of NMP altogether
Table 1. 
Clinical results observed to date with application of normothermic regional perfusion in donation after 
circulatory death organ transplantation.
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